GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 15.37
+0.62 (4.20%)
At close: Mar 6, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 6.3 billion as of March 6, 2026. Its market cap has increased by 10.59% in one year.
Market Cap
6.30B
Enterprise Value
5.43B
Revenue
793.25M
Ranking
n/a
PE Ratio
43.91
Stock Price
15.37
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has decreased from 7.59B to 6.30B, a decrease of -16.92%. That is a compound annual growth rate of -4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.30B | 0.07% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Weiguang Biological Products | 6.57B |
| Lifecome Biochemistry | 6.54B |
| Beijing Konruns Pharmaceutical | 6.34B |
| R&G PharmaStudies | 6.31B |
| Xiangxue Pharmaceutical | 6.22B |
| Shanghai OPM Biosciences | 5.92B |
| Novogene | 5.75B |
| Kexing Biopharm | 5.70B |